MiNK Therapeutics, Inc. (INKT)
Nasdaq: INKT · CIK 0001840229 · United States
Every official MiNK Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open INKT filings
MiNK Therapeutics, Inc. documents
- MiNK Therapeutics, Inc. 10-K 2026INKT 10-K 2026: annual report for fiscal 2026
- MiNK Therapeutics, Inc. 10-K 2025INKT 10-K 2025: annual report for fiscal 2025
- MiNK Therapeutics, Inc. 10-K 2024INKT 10-K 2024: annual report for fiscal 2024
- MiNK Therapeutics, Inc. 10-K 2023INKT 10-K 2023: annual report for fiscal 2023
- MiNK Therapeutics, Inc. 10-K 2022INKT 10-K 2022: annual report for fiscal 2022
- MiNK Therapeutics, Inc. 10-Q 2026INKT 10-Q 2026: quarterly report for fiscal 2026
- MiNK Therapeutics, Inc. 10-Q 2025INKT 10-Q 2025: quarterly report for fiscal 2025
- MiNK Therapeutics, Inc. 10-Q 2024INKT 10-Q 2024: quarterly report for fiscal 2024
- MiNK Therapeutics, Inc. 10-Q 2023INKT 10-Q 2023: quarterly report for fiscal 2023
- MiNK Therapeutics, Inc. 10-Q 2022INKT 10-Q 2022: quarterly report for fiscal 2022
- MiNK Therapeutics, Inc. 8-K 2026INKT 8-K 2026: current report for fiscal 2026
- MiNK Therapeutics, Inc. 8-K 2025INKT 8-K 2025: current report for fiscal 2025
- MiNK Therapeutics, Inc. 8-K 2024INKT 8-K 2024: current report for fiscal 2024
- MiNK Therapeutics, Inc. 8-K 2023INKT 8-K 2023: current report for fiscal 2023
- MiNK Therapeutics, Inc. 8-K 2022INKT 8-K 2022: current report for fiscal 2022
- MiNK Therapeutics, Inc. DEF 14A 2026INKT DEF 14A 2026: proxy statement for fiscal 2026
- MiNK Therapeutics, Inc. DEF 14A 2025INKT DEF 14A 2025: proxy statement for fiscal 2025
- MiNK Therapeutics, Inc. DEF 14A 2024INKT DEF 14A 2024: proxy statement for fiscal 2024
- MiNK Therapeutics, Inc. DEF 14A 2023INKT DEF 14A 2023: proxy statement for fiscal 2023
- MiNK Therapeutics, Inc. DEF 14A 2022INKT DEF 14A 2022: proxy statement for fiscal 2022
- MiNK Therapeutics, Inc. Form 4 2026INKT Form 4 2026: insider trading filing for fiscal 2026
- MiNK Therapeutics, Inc. Form 4 2025INKT Form 4 2025: insider trading filing for fiscal 2025
- MiNK Therapeutics, Inc. Form 4 2024INKT Form 4 2024: insider trading filing for fiscal 2024
- MiNK Therapeutics, Inc. Form 4 2023INKT Form 4 2023: insider trading filing for fiscal 2023
- MiNK Therapeutics, Inc. Form 4 2022INKT Form 4 2022: insider trading filing for fiscal 2022
- MiNK Therapeutics, Inc. S-1 2026INKT S-1 2026: registration statement for fiscal 2026
- MiNK Therapeutics, Inc. S-1 2025INKT S-1 2025: registration statement for fiscal 2025
- MiNK Therapeutics, Inc. S-1 2024INKT S-1 2024: registration statement for fiscal 2024
- MiNK Therapeutics, Inc. S-1 2023INKT S-1 2023: registration statement for fiscal 2023
- MiNK Therapeutics, Inc. S-1 2022INKT S-1 2022: registration statement for fiscal 2022
- MiNK Therapeutics, Inc. 13F 2026INKT 13F 2026: institutional holdings for fiscal 2026
- MiNK Therapeutics, Inc. 13F 2025INKT 13F 2025: institutional holdings for fiscal 2025
- MiNK Therapeutics, Inc. 13F 2024INKT 13F 2024: institutional holdings for fiscal 2024
- MiNK Therapeutics, Inc. 13F 2023INKT 13F 2023: institutional holdings for fiscal 2023
- MiNK Therapeutics, Inc. 13F 2022INKT 13F 2022: institutional holdings for fiscal 2022
More companies